Who is sponsoring NCT03900078?

NCT03900078 is sponsored by Ruhr University of Bochum.

What drugs are being tested in NCT03900078?

Interventions in NCT03900078: Incisional negative pressure wound therapy, Wound dressing with adhesive tapes.

What condition does NCT03900078 study?

NCT03900078 studies Soft Tissue Sarcoma, Lipoma, Tumor.

Is NCT03900078 still recruiting?

NCT03900078 is currently completed. Last updated 8 October 2020.

Last reviewed 2020-10-08 · How we verify

NCT03900078

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Incisional Negative Pressure Wound Therapy for Resection of Soft Tissue Tumors

Completed NA Last updated 8 October 2020

What this trial tests

NA trial testing Incisional negative pressure wound therapy in Soft Tissue Sarcoma in 60 participants. Completed in 15 September 2020.

Timeline

1 December 2018

Primary endpoint
1 August 2020

15 September 2020

Quick facts

Lead sponsor	Ruhr University of Bochum
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	60
Start date	1 December 2018
Primary completion	1 August 2020
Estimated completion	15 September 2020
Sites	1 location across Germany

Drugs / interventions tested

Incisional negative pressure wound therapy
Wound dressing with adhesive tapes

Conditions studied

Soft Tissue Sarcoma — all drugs for Soft Tissue Sarcoma →
Lipoma — all drugs for Lipoma →
Tumor — all drugs for Tumor →

Sponsor

Ruhr University of Bochum

Who can join

18 and older, any sex, with Soft Tissue Sarcoma or Lipoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is aimed to examine the value of incisional negative pressure therapy after resection of soft tissue tumors. Its a prospective randomized trial comparing incisional negative pressure to standard wound dressings.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Negative pressure wound therapy for surgical wounds healing by primary closure.
Norman G, Shi C, Goh EL, Murphy EM, et al · · 2022 · cited 71× · PMID 35471497 · DOI 10.1002/14651858.cd009261.pub7
Negative pressure wound therapy for surgical wounds healing by primary closure.
Norman G, Goh EL, Dumville JC, Shi C, et al · · 2020 · cited 48× · PMID 32542647 · DOI 10.1002/14651858.cd009261.pub6
Negative pressure wound therapy for surgical wounds healing by primary closure.
Norman G, Goh EL, Dumville JC, Shi C, et al · · 2020 · cited 38× · PMID 32356396 · DOI 10.1002/14651858.cd009261.pub5
A Systematic Review and Meta-Analysis of Negative Wound Pressure Therapy Use in Soft Tissue Sarcoma Resection.
Gusho C, Phillips R, Cook J, Evenski A. · · 2023 · cited 3× · PMID 38213851

Verify or expand the search:

Other trials of Incisional negative pressure wound therapy

Trials testing the same drug.

NCT05716490 — Optimizing Closed Incision Negative Pressure Wound Therapy in Emergency Laparotomy · NA · completed

Other recruiting trials for Soft Tissue Sarcoma

Currently open trials in the same condition.

NCT07261631 — Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors · Phase 1 · recruiting
NCT07243626 — Efficacy and Safety of Envafolimab Plus Doxorubicin and Ifosfamide for Advanced Soft Tissue Sarcoma · Phase 2 · recruiting
NCT07049848 — SATURN-STS: Phase II Study of Neoadjuvant Atezolizumab With Doxorubicin, Concurrent Atezolizumab With Pre-operative Radi · Phase 2 · recruiting
NCT06962072 — Outcomes Following Limb Sparing Surgery for Soft Tissue Sarcoma · recruiting
NCT06905132 — Preoperative 5-Day Radiotherapy for Soft Tissue Sarcoma · Phase 2 · recruiting

Other Ruhr University of Bochum trials

Trials by the same sponsor.

NCT07432945 — In Vivo Exposure vs. Videochat-Based Vicarious Exposure · NA · recruiting
NCT06255821 — The Effect of Time on Generalization of Exposure-based Benefit · NA · completed
NCT05824884 — Self-efficacy Enhancement in a Virtual Reality Training for Fear of Heights · NA · recruiting
NCT05798078 — The Relationship Between Social Anxiety and Anxious Thinking Styles · NA · completed
NCT05780203 — CBM in the Context of Exposure for Acrophobia · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03900078 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ruhr University of Bochum
Last refreshed: 8 October 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03900078.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing